NCT02299661 - Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Chronic Renal DiseaseRenal Anemia

Interventions

DRUG

DS-1093a

DS-1093a, single oral doses up to 50 mg

Trial Locations (3)

: Hemodialysis Center, Teaching Hospital Hradec Králove, Hradec Králové

PRA Clinical Pharmacology Unit, Prague

PRA Clinical Pharmacology Unit, Budapest